Neurovascular Diagnostics Received $750,000 Phase II SBIR funding from the NSF
A UB spinoff company that is developing a low-cost blood test to screen high-risk patients for unruptured brain aneurysms has […]
Neurovascular Diagnostics Received $750,000 Phase II SBIR funding from the NSF Read More »